Clinical trial

Grey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T MRI Study

NCT03659981

StatusACTIVE_NOT_RECRUITING
Study typeINTERVENTIONAL
Start date2018-12-20
PhaseNA

Study timeline

Study start (actual)2018-12-20Date precision: day
Registry last updated2024-08-06
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.